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CObjectives: The primary aim was to assess the equivalence of an
Internet-based chronic obstructive pulmonary disease–population
screener (COPD-PS) relative to a validated paper-and-pencil version.
A secondary aim was to compare groups based on known COPD risk
factors, such as smoking status and gender. Methods: Using an on-
line panel survey organization, participants were randomized to in-
ternet or paper-and-pencil assessment where they completed the
COPD-PS and other study forms. A subset of respondents also com-
pleted a test-retest reliability assessment. Finally, several thousand
additional online respondents completed the COPD-PS for risk factor
analyses. Results: A total of 1006 adults completed the randomized
tudy (N  504 online, N  502 by mail). There were no differences
etween the arms in mean COPD-PS scores (mean difference: 0.12; 95%
onfidence interval: 0.14–0.37; P  0.365). In the web arm, 106/504 O
f Med
al So
doi:10.1016/j.jval.2010.10.03521.0%) exceeded the screening cut-off compared to 101/502 (20.1%) in
he paper-administration arm (difference in proportions: 0.9%; 95%
onfidence interval: 4.1%–5.9%; P  0.720). Subgroup analyses on a
eparate cohort of 3001 adults demonstrated hypothesized differences
etween groups defined by smoking status, presence of COPD, and
hortness of breath. Conclusion: The methods of administration that
ere evaluated in this study (internet vs. paper and pencil) resulted in
o significant differences in COPD-PS mean scores. Furthermore, the
redictive utility of the COPD-PS was not different between methods of
dministration, even after accounting for age and smoking status.
eywords: chronic obstructive pulmonary disease (COPD), screening,
hortness of breath, smoking.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Chronic obstructive pulmonary disease (COPD) is a complex and
challenging public health problem in the US and around the world.
Estimates of the number of US patients affected by COPD ranges
from 10 million to 24.5 million [1]. COPD is currently the fourth
major cause of death in the US, and a significant degree of health
care utilization is attributed to it, including approximately 726,000
hospitalizations, 1.5 million visits to the emergency room and ap-
proximately 8 million outpatient physician visits per year [2]. In
addition, COPD is a major source of disability and impaired health-
related quality of life (HRQL) [1].
Because the clinical course of the disease can be improved and
he risk of exacerbations can be reduced, early identification is
ery important [3]. The United States Preventive Services Task
orce (USPSTF) has recommended against the use of spirometry as
screening tool and indicated a need for research to evaluate
hether primary care screening for smoking history and respira-
ory symptoms can detect severe COPD [4]. A standardized COPD
creening tool appropriate for primary care use would, therefore,
ave the potential to identify symptoms prior to patients’ first
* Address correspondence to: Jennifer Beaumont, Department o
60611 USA.
E-mail: j-beaumont@northwestern.edu.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.exacerbations, thus maximizing early intervention and disease
management efforts.
In order to better understand and identify those who are likely to
have COPD, the COPD Population Screener (COPD-PS; Quality Metric
Incorporated, Lincoln, RI) was developed and validated [5]. It is a brief
(five item), self-reported and scored questionnaire that focuses on
five important domains known to predict airway obstruction consis-
tent with this disease (breathlessness in the past 4 weeks, productive
cough frequency, impact of breathing problems on activity level over
the past year, smoking history – at least 100 cigarettes in entire life,
current age) (see doi:10.1016/j.jval.2010.10.035). For a detailed de-
scription on the development, initial validation, scoring and inter-
pretation of the COPD-PS, please see Martinez [5]. In brief, item re-
sponses are assigned a score (0, 1, or 2) dependent on their
demonstrated level of association with fixed airflow obstruction and
item scores are summed. Calculated scores range from 0 to 10 and a
cut-point in the range of 5 to 6 points was found to provide good
sensitivity and specificity [5]. The COPD-PS user’s guide recommends
a threshold of5.
In order to accommodate linguistic, cultural, educational, and
functional issues, patients, clinicians and researchers must have
ical Social Sciences, 710 N Lake Shore Dr, 7th floor, Chicago, IL
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
t
a
d
R
s
n
H
r
t
p
i
m
p
p
m
t
e
t
f
m
e
w
o
r
s
p
d
t
a
t
t
w
w
r
i
s
507V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 0 6 – 5 1 2flexibility in choosing appropriate methods (e.g., paper-and-pen-
cil, internet) and modes (e.g., self-administration, interview-
based) of questionnaire administration for HRQL and other pa-
tient-reported outcomes (PROs) [6,7]. It is important to ensure that
he benefits of flexibility in administration methods and modes
re not overshadowed by the possibilities of biased measurement.
Some research has been conducted to evaluate the effects of
ifferent methods and modes of administration on PRO responses.
esearch has primarily been motivated by the need to demon-
trate that different methods and modes of administration will
ot bias the measurement of PRO data. Because computerized
RQL assessment has not yet been widely implemented, much
esearch to date has naturally focused on interview (in-person or
elephone) versus self-administration (in the clinic or by mail) of
aper-and-pencil questionnaires. Many of these research designs
nvolved the randomization of study participants to different
ethods and/or modes, while some involved within-subject com-
arisons through the use of crossover designs. Most studies re-
orted high reliability for instruments administered with different
ethods/modes, but response effects varied and were not consis-
ently in the same direction. For example, some studies found
vidence of more favorable reports of well-being on self-adminis-
ered questionnaires [8,9], whereas others found the opposite ef-
ect [10–12]. However, the majority have found no differences due to
ethod/mode of administration [11,13–20].
With advanced applications in the administration of PRO mea-
sures (e.g., specialized branching, adaptive testing [21]), the use of
computers has become increasingly important. A recent meta-
analysis [22] highlighted the overall equivalence between comput-
r-based and paper-and-pencil based methods of administration,
hich was not significantly affected by age, computer experience,
r computer platform.
The internet has increasingly become an important tool for
esearch and clinical use. The majority of recent studies have
uggested psychometric equivalence between internet and pa-
er-and-pencil based tests [23]. However, some have reported
ecreased social anxiety and social desirability when using in-
ernet versions [24] and others have reported equivocal findings
s to whether internet users employ more extreme responses
han paper-and-pencil responders [25,26]. Thus it is important
o validate internet tests to ensure measurement equivalence
ith paper-and-pencil counterparts. The purpose of this study
as to assess the equivalence of an internet-based COPD-PS
elative to the validated paper-and-pencil COPD-PS, and exam-
ne the effects of gender, smoking status, and disease status on
elf-reported COPD symptomatology.
Participants and Methods
Data were collected from two separate samples. The first was used
to evaluate the effects of different administration methods, and
the second was used to examine the sensitivity of the COPD-PS
with known COPD risk factors. In the first sample, a two-arm ran-
domized study of internet versus paper and pencil was conducted
with over 1000 adults at least 35 years old. Participants were en-
rolled by an online panel survey organization such that the final
sample could be nationally representative through propensity
weighting procedures to yield census-equivalent results. There
are 1.5 million panelists in the United States who have agreed to
participate in web-based surveys from which the samples were
drawn. Panelists are continuously enrolled by various recruitment
methods and are not paid to join the panel but do receive incen-
tives to complete individual surveys through participation in a
loyalty program. Participants were randomly selected from the
pool of panel participants to complete either the internet or paper-
and-pencil assessment. Participants randomly selected for the in-
ternet group completed the assessment online. The COPD-PS waspresented with one question on the screen at a time. Participants
randomly selected for the paper-and-pencil group were asked to
complete a paper-and-pencil version, sent the paper-and-pencil
version following agreement to participate, and the completed
form was received via mail. Once received, the data were entered
and analyzed with the internet administration data. This study
was approved and designated exempt by the NorthShore Univer-
sity HealthSystem Institutional Review Board.
All participants completed a set of socio-demographic and
clinical questions, the COPD population screener (COPD-PS), the
Medical Research Council (MRC) dyspnea scale [27], and a brief
feasibility/acceptability survey. The clinical questions consisted of
a self-report of medical diagnoses in a manner consistent with the
National Health and Nutrition Examination Survey (NHANES). The
MRC was included both to characterize the sample and to eval-
uate the ability of the COPD-PS in each arm to differentiate
between definable, known groups as a confirmation of validity.
To assess online test-retest reliability, a subset of 100 partici-
pants from the online assessment arm were asked to complete
the COPD-PS a second time, approximately 5 to 7 days after
completing the initial assessment.
To examine the sensitivity of the COPD-PS on known risk
factors, an additional 3001 participants were recruited to par-
ticipate in the internet-based portion of the study. These data
were collected to allow for evaluations of the COPD-PS in sub-
groups defined by gender, smoking status, and disease diagno-
ses, given that smoking is the greatest risk factor for COPD and
women are diagnosed with COPD at twice the rate of men [28].
Statistical analysis
For the equivalence analysis, sociodemographic and clinical char-
acteristics were compared between the two randomized groups
using independent t tests for continuous variables and Pearson
chi-square statistics for nominal variables. In a randomized study
such as this, it is expected that the randomized groups should be
balanced on all measured and unmeasured characteristics. Thus,
in the presence of equivalent methods, response frequencies for
the five COPD-PS items, mean index scores, and proportion scor-
ing at or above the threshold value of five should be comparable in
the two groups. As mentioned previously, the COPD-PS user’s
guide recommends a threshold of five for indication of possible
COPD. Ninety-five percent confidence intervals (CI) were calcu-
lated for the difference between randomized groups and the con-
fidence limits evaluated to determine whether or not a clinically
meaningful difference was present.
The primary purpose of the COPD-PS is as a screening tool to
identify persons with a high likelihood of having COPD. Therefore,
logistic regression was used to evaluate whether the predictive
utility of the COPD-PS differed by method of administration. The
dependent variable in this logistic regression model was the par-
ticipants’ self-reported diagnosis of COPD on the medical condi-
tions list; independent variables were group (paper and pencil ver-
sus internet), COPD-PS screening status (COPD-PS score  5 vs.
5) and the interaction between those two factors. We also exam-
ined the impact of covariates (age, smoking) on this relationship.
Test-retest reliability was assessed using the intraclass correlation
coefficient. The frequency distribution of the MRC scale was sum-
marized. We conducted cross-sectional analyses of scores focused
on differentiating definable (“known”) groups defined according to
the MRC. Analysis of variance techniques were used to compare
mean COPD-PS scores by MRC categories. It was expected that
patients with worse MRC would have higher COPD-PS mean
scores. Effect sizes (mean difference/pooled standard deviation)
were calculated for group comparisons to provide an indication of
the magnitude of these group differences.
For the risk factor analysis, sociodemographic and clinical
characteristics were compared between the original sample and
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variables and Pearson chi-square statistics for nominal variables.
Responses on the COPD-PS were compared between groups de-
fined by gender, smoking status, COPD, and shortness of breath.
Sample size considerations
Sample size calculations were based on achieving a desired level
of precision in the estimation of group differences. Assuming an
expected difference between groups of zero, to achieve a precision
of 0.15 effect size units (95% CI), would require 342 participants
per group. Assuming a 10% prevalence of COPD in the population
under study, to achieve a precision of4% would require 481 par-
ticipants per group. Therefore, we elected to enroll 1000 partici-
Fig. 1 – Participant flow into randomized study.
Table 1 – Demographic characteristics of the randomized s
Ran
Paper and pencil
(n  502)
Male 233 (46.4%)
Age
Mean (SD) 55.6 (10.8) 5
Hispanic 38 (7.6%)
Race
White 419 (83.5%)
Black/African American 38 (7.6%)
Other 44 (8.8%)
Not provided 1 (0.2%)
Married or living with partner 363 (72.3%)
Education
Less than high school 20 (4.0%)
High school or GED 192 (38.4%)
Some college/technical degree 151 (30.2%)
College degree or higher 137 (27.4%)
Family income
$40,000 175 (34.9%)
$40,000–$60,000 97 (19.3%)
$60,000 215 (42.8%)
Did not answer 15 (3.0%)
Current smoker 103 (20.5%)
Numbers in table are N (percent of non-missing values) except wher
GED, general education diploma; SD, standard deviation.
* “Not provided” combined with “other” due to small cell size.
† “Did not answer” excluded from group comparison.pants in the equivalence sample, randomly selected to two equal
sized groups of 500. The risk factor sample size of 3000 additional
participants was also powered to detect a large effect size should
group differences exist.
Results
Participant flow
A total of 3280 panel participants were randomly selected and
invited to complete the COPD-PS and accompanying forms by pa-
per and pencil (n  767) or the internet (n  602) to achieve the
esired sample size per group. Just over 50% of those who were
nvited (n  1650) did not respond to the original request. Of the
aper-and-pencil respondents who were selected, 65.4% (n 502)
ompleted the questionnaire, whereas 83.7% of the internet re-
pondents (n  504) completed the questionnaire (Fig. 1).
Sociodemographic characteristics – randomized study
Forty-seven percent of the initial randomized study sample was
male and the mean age was 55.0 years old (standard deviation
[SD], 11.4 years) (Table 1). The majority of the sample was white,
9.4% black or African American, and 7.3% Hispanic. There were
substantially more smokers in the internet-administration arm
(29.4%) compared to the paper-administration arm (20.5%; P 
0.001). No statistically significant group differences were found
between the randomized arms with regard to self-reported comor-
bid medical conditions (Table 2). The greatest proportion of par-
ticipants reported back pain and arthritis (35.0% and 34.2%, re-
spectively), whereas respiratory disorders such as chronic
sample and the risk factor sample.
ized study sample
Risk factor
sample
rnet
504)
All
(n  1,006)
P value All
(n  3,001)
7.6%) 473 (47.0%) 0.702 1437 (47.9%)
1.9) 55.0 (11.4) 0.095 53.4 (11.7)
.9%) 73 (7.3%) 0.702 365 (12.2%)
0.112*
1.0%) 827 (82.2%) 2379 (79.3%)
1.3%) 95 (9.4%) 366 (12.2%)
.7%) 78 (7.8%) 235 (7.8%)
.0%) 6 (0.6%) 21 (0.7%)
7.3%) 702 (69.8%) 0.081 2071 (69.2%)
0.354
.0%) 45 (4.5%) 139 (4.6%)
3.1%) 359 (35.8%) 1099 (36.6%)
2.1%) 313 (31.2%) 911 (30.4%)
9.8%) 287 (28.6%) 850 (28.3%)
0.152†
3.9%) 346 (34.4%) 1099 (36.6%)
4.0%) 218 (21.7%) 645 (21.5%)
8.5%) 409 (40.7%) 1177 (39.2%)
.6%) 33 (3.3%) 80 (2.7%)
9.4%) 251 (25.0%) 0.001 757 (25.3%)
rwise noted.tudy
dom
Inte
(n 
240 (4
4.5 (1
35 (6
408 (8
57 (1
34 (6
5 (1
339 (6
25 (5
167 (3
162 (3
150 (2
171 (3
121 (2
194 (3
18 (3
148 (2
e othe
t
a
T
i
t
r
c
p
h
r
g
t
e
509V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 0 6 – 5 1 2bronchitis and emphysema were more infrequent (3.3% and 2.6%,
respectively).
Influence of method – equivalence results
Response frequencies for the five COPD-PS items, mean index
scores, and proportion scoring at or above the threshold value of
five are presented in Table 3. The two arms were comparable for
responses to the first three questions of the COPD-PS. Participants
in the internet administration were more likely to have smoked at
least 100 cigarettes in their lifetime (64.5% vs. 57.0%; P 0.044) and
were younger than the paper-and-pencil administration group
(39.8% under 50 vs. 31.9%; P 0.011). This is consistent with the age
and smoking information collected on the socio-demographic
form and reported in Table 1. There were no statistically signifi-
cant differences between the arms in mean COPD-PS scores (mean
difference: 0.12; 95% CI: 0.14 to 0.37; P  0.365). The distribu-
tions of scores in each group are presented in Figure 2. In the
paper-and-pencil arm, 20.1% (n101) exceeded the screening cut-
off compared to 21.0% (n106) in the internet arm (difference in
proportions: 0.9%; 95% CI: 4.1%–5.9%; P  0.720).
In a logistic regression model with COPD diagnosis (self-re-
ported) as the dependent variable and COPD-PS screening status
and randomized arm as the independent variables, the interaction
between screening status and study arm was not statistically sig-
nificant (chi-square  0.915; P  0.339), indicating that the predic-
ive utility of the COPD-PS did not differ by study arm. Inclusion of
ge or smoking as a covariate had no impact on this relationship.
he test-retest reliability of the COPD-PS score was good, with an
ntraclass correlation coefficient (ICC) of 0.82. Test-retest reliabili-
ies for the individual questions were also quite good with ICCs
anging from 0.78 (smoking) to 0.99 (age) (Table 3).
COPD-PS scores successfully differentiated groups defined ac-
ording to the MRC (Table 4) in both the internet and paper-and-
encil groups. As expected, participants with worse MRC had
igher COPD-PS mean scores. Effect sizes were well within the
ange that is generally considered clinically meaningful (i.e.,
reater than 0.40).
Nearly all participants reported using a computer and the in-
ernet regularly and 98.4% reported that it was “easy” or “very
Table 2 – Clinical characteristics of the randomized study s
Currently have any of the following conditions
diagnosed by a doctor, nurse, or other health
care professional?
Paper and pen
(n  502) %
Back pain 36.2
Arthritis 34.1
Hypertension 27.1
Acid reflux 18.5
Insomnia 16.5
Depression 15.7
Anxiety 12.8
Migraine/headaches 13.6
Diabetes 10.8
Asthma 10.8
Fibromyalgia/chronic fatigue 6.6
COPD 4.6
Coronary artery disease 3.8
Chronic bronchitis 3.4
Emphysema 2.6
COPD, chronic obstructive pulmonary disease.asy” to use the internet to answer the survey questions.Influence of risk factors - subgroup results
For the risk factor analysis phase of data collection, an additional
7852 English speakers were invited to complete the survey. Of
these, 3885 initiated the online survey, of which 67 were deter-
mined to be ineligible and 3001 completed the entire survey. Com-
pared to the original randomized study sample, this additional
sample included significantly more Hispanics and self-reported
asthmatics, so the two samples were not pooled. The final col-
umns of Tables 1 and 2 present the demographic and clinical char-
acteristics of this additional sample of 3001 respondents.
Table 5 presents COPD-PS mean scores and proportion scoring
at or above the threshold value of 5 by gender, smoking status,
COPD, and shortness of breath. Mean COPD-PS scores and propor-
tion scoring above the threshold did not differ by gender. As ex-
pected, smokers reported higher mean COPD-PS scores and a
greater proportion scoring five or higher, as did participants with
shortness of breath or self-reported COPD.
Discussion
The methods of administration that were evaluated in this study
(internet vs. paper and pencil) resulted in no significant differ-
ences in COPD-PS mean scores. Furthermore, the predictive utility
of the COPD-PS was not different between methods of administra-
tion, even after accounting for age and smoking status. Both pa-
per-and-pencil and internet administration result in valid and
comparable screening data. Researchers, clinicians, and patients
will now be able to select the method of their choice for future uses
of the COPD-PS. Furthermore, demonstrated equivalence of these
two methods may allow for use of either method in a single cohort
screening effort.
Although the percentage of current smokers from this sample
(25%) largely mirrors US population estimates (between 21% and
25%) [29–31], rates of current smoking status and endorsement of
smoking at least 100 cigarettes in one’s lifetime were significantly
higher among internet respondents (who were also significantly
younger than paper-and-pencil respondents) compared to their
paper-and-pencil counterparts. This difference may reflect a ten-
dency to respond more openly over the internet as a result of
increased perceptions of anonymity and lower social desirability
le and the risk factor sample.
andomized study sample
Risk factor
sample
Internet
(n  504) %
All
(n  1,006) %
P value All
(n  3,001) %
33.7 35.0 0.401 33.8
34.3 34.2 0.930 30.1
27.6 27.3 0.862 23.3
20.4 19.5 0.444 19.8
17.9 17.2 0.578 18.2
17.1 16.4 0.570 16.6
14.1 13.4 0.534 13.7
10.9 12.2 0.202 14.5
12.5 11.6 0.389 13.1
7.5 9.2 0.077 13.1
6.8 6.7 0.913 8.0
4.6 4.6 0.989 4.5
4.6 4.2 0.537 4.0
3.2 3.3 0.850 4.4
2.6 2.6 0.992 2.6amp
R
cildemands [24]. In addition, paper-and-pencil respondents may
* Intra-class correlation coefficient; test-retest evaluated in internet group only.
510 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 0 6 – 5 1 2Fig. 2 – Distribution of chronic obstructive pulmonary disease–population screener (COPD-PS) scores: (A) paper-and-pencilTable 3 – Responses on the COPD-PS – randomized study.
Paper and pencil
(n  502)
Internet
(n  504)
All
(n  1,006)
P value Reliability*
(n  100)
During the past 4 weeks, how much of the
time did you feel short of breath?
0.238 0.79
None of the time 215 (42.8%) 243 (48.2%) 458 (45.5%)
A little of the time 179 (35.7%) 153 (30.4%) 332 (33.0%)
Some of the time 87 (17.3%) 82 (16.3%) 169 (16.8%)
Most of the time 18 (3.6%) 19 (3.8%) 37 (3.7%)
All of the time 3 (0.6%) 7 (1.4%) 10 (1.0%)
Do you ever cough up any “stuff,” such as
mucous or phlegm?
0.097 0.81
No, never 100 (19.9%) 80 (15.9%) 180 (17.9%)
Only with occasional colds 261 (52.0%) 253 (50.2%) 514 (51.1%)
Yes, a few days a month 71 (14.1%) 99 (19.6%) 170 (16.9%)
Yes, most days of a week 48 (9.6%) 44 (8.7%) 92 (9.2%)
Yes, every day 22 (4.4%) 28 (5.6%) 50 (5.0%)
(In the past 12 months) I do less than I used to
because of my breathing problems
0.176 0.82
Strongly disagree 223 (44.4%) 200 (39.7%) 423 (42.0%)
Disagree 157 (31.3%) 157 (31.2%) 314 (31.2%)
Unsure 38 (7.6%) 60 (11.9%) 98 (9.7%)
Agree 65 (13.0%) 69 (13.7%) 134 (13.3%)
Strongly agree 19 (3.8%) 18 (3.6%) 37 (3.7%)
Have you smoked at least 100 cigarettes in
your entire life?
0.044 0.78
No 205 (40.8%) 172 (34.1%) 377 (37.5%)
Yes 286 (57.0%) 325 (64.5%) 611 (60.7%)
Don’t know 11 (2.2%) 7 (1.4%) 18 (1.8%)
How old are you? 0.011 0.99
35 to 49 years old 160 (31.9%) 200 (39.8%) 360 (35.9%)
50 to 59 years old 166 (33.1%) 142 (28.3%) 308 (30.7%)
60 to 69 years old 126 (25.1%) 98 (19.5%) 224 (22.3%)
70 years old 50 (10.0%) 62 (12.4%) 112 (11.2%)
COPD-PS score 0.82
Mean (SD) 2.96 (2.03) 3.08 (2.07) 3.02 (2.05) 0.365
COPD-PS score 5 101 (20.1%) 106 (21.0%) 207 (20.6%) 0.720
COPD-PS, chronic obstructive pulmonary disease–population screener; SD, standard deviation.group; (B) internet group.
t
t
f
s
d
m
e
e
511V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 5 0 6 – 5 1 2have also experienced decreased feelings of anonymity and/or in-
creased feelings of supervision or monitoring by receiving a
mailed packet of measures directed to their attention and home
address. Nevertheless, debate currently exists surrounding the
“candor hypothesis” of online testing [32], and future mode stud-
ies should examine these effects when possible.
Consistent with the COPD literature [28,31], our findings from
he additional online risk factor testing with several thousand par-
icipants confirmed that being a current smoker is indeed a risk
actor for COPD symptomatology. This additional testing further
upported the construct validity of the COPD-PS, as online respon-
ents with self-reported COPD or shortness of breath scored
eaningfully higher than those with no reported disorder.
Given the widespread burden of COPD, this brief, flexible and
asy to administer screening tool can have far-reaching impact on
arly disease identification and subsequent prevention and con-
Table 4 – COPD-PS scores by MRC group* - randomized
study.
Mean COPD-PS
score (SD)
Effect
size
P value
Paper and pencil
MRC 1 (n  280) 2.39 (1.70) 1 vs. 2: 0.72 0.001
MRC 2 (n  201) 3.61 (2.13) 2 vs. 3: 0.78
MRC 3 (n  15) 5.27 (2.37)
Internet
MRC 1 (n  265) 2.46 (1.58) 1 vs. 2: 0.69 0.001
MRC 2 (n  210) 3.54 (2.11) 2 vs. 3: 1.58
MRC 3 (n  19) 6.89 (2.60)
COPD-PS, chronic obstructive pulmonary disease–population
screener; MRC, Medical Research Council dyspnea scale.
* 1  only breathless after strenuous exercise; 2  only breathless
when hurrying on level ground or walking up a slight hill; 3 had
to walk slower than other people on level ground because of
breathlessness or had to stop for breath even when walking at my
own pace.
Table 5 – COPD-PS scores by group.
Mean COPD-PS
score (SD)
N (%) with
COPD-PS 5
Gender
Male (n  1437) 2.90 (2.0) 246 (17.1)
Female (n  1564) 2.85 (1.95) 262 (16.8)
P value 0.570 0.789
Current smoking status
Smoker (n  757) 3.68 (1.64) 177 (23.4)
Non-smoker (n  2241) 2.60 (2.00) 331 (14.8)
P value 0.001 0.001
Self-reported COPD
COPD (n  134) 6.31 (1.99) 106 (79.1)
No COPD (n  2867) 2.72 (1.82) 402 (14.0)
P value 0.001 0.001
Shortness of breath in the
past 4 weeks
Any shortness of breath
(n  1423)
3.59 (2.16) 436 (30.6)
No shortness of breath
(n  1574)
2.23 (1.52) 74 (4.7)
P value 0.001 0.001
COPD-PS, chronic obstructive pulmonary disease–population
screener; SD, standard deviation.trol efforts. It should be noted that the COPD-PS is a screening tool
to identify those at risk for COPD and a diagnosis of COPD needs to
be confirmed as per guidelines. Its ability to be used over the in-
ternet allows for countless applications for efficient, cost-effective
and real time data capture that can be seamlessly integrated into
tailored public health databases and intervention initiatives. The
sensitivity the COPD-PS displays among known risk factors, such
as smoking, gender and disease characteristics, lends itself well to
future studies with higher risk target populations.
This study is not without limitations. Similar to other studies that
collect self-reported data on behaviors, such as smoking, respon-
dents may not have accurately reported their behaviors due to a host
of variables, such as general recall difficulties to social desirability.
The enrollment rate was lower for individuals selected into the pa-
per-and-pencil administration arm. This relatively higher reluctance
to participate in the paper-and-pencil arm of the study may have
introduced some degree of bias. Unfortunately, little data were avail-
able on the non-enrolled individuals to examine the potential extent.
Furthermore, it is important to note that these samples were selected
from a pool of internet users. It is not clear how these results would
generalize to nonusers. This sample is also likely underrepresented
by those who are disabled or who have lower literacy levels. None-
theless, we believe that using the internet as a method of self assess-
ment may help decrease social desirability effects as well as personal
and environmental burden.
Conclusion
The methods of administration that were evaluated in this study
(internet vs. paper and pencil) resulted in no significant differ-
ences in COPD-PS mean scores. This new internet-compatible
screening tool has the potential to contribute to access and help
change the landscape of early COPD identification.
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